Vrtx. Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases.
Vrtx. Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases.
Today's Vrtx.com headlines: Observe fresh posts and updates on Vrtx. This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Vrtx.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.
LONDON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the European Commission has granted Marketing Authorization for ORKAMBI® (lumacaftor/ivacaftor), the first medicine to treat the underlying cause of cystic...
BOSTON — The approval of Vertex Pharmaceuticals Inc.’s Orkambi (lumacaftor/ivacaftor) is being hailed as a big stride forward in the treatment of cystic fibrosis. Orkambi is the first medication to treat the underlying cause of cystic fibrosis in people...
Michael Partridge - Vice President-Investor Relations Good evening, everyone. This is Michael Partridge, Head of Investor Relations for Vertex Pharmaceuticals. Welcome to our Second Quarter 2015 Financial Results Conference Call. At this time, all participants...
Vertex Pharmaceuticals and Parion Sciences have teamed up to develop new drugs for treatment of cystic fibrosis (CF) and other pulmonary diseases. The companies have initiated a collaboration worth up to $1.17 billion, under which Vertex and Parion...
DENVER, CO, United States, via ETELIGIS INC., 10/02/2014 – - United Cannabis Corporation (OTCQB: CNAB) (the “Company” or “United Cannabis”) today announced that it has participated with a small group of Jamaicans to form a Jamaican corporation named...
SOCRATES Journal is an international, refereed, and indexed scholarly publication focused on public policy, administration, and ph...
MiniWrites – A hub for your creative projects!
A hub for your creative projects!
Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases.
KALYDECO is a registered trademark of Vertex Pharmaceuticals Incorporated authorized for use in Canada by Vertex Pharmaceuticals (Canada) Incorporated. KALYDECO est une marque de commerce déposée de V...
The Science of Possibility. Vertex creates new possibilities in medicine to cure diseases and improve people's lives.
25 years
Domain age
00:01:19
Visit duration
2.1K
Daily visitors
57%
Bounce rate
N/A
Child safety
Excellent
Trust
Excellent
Privacy
67.8 %
USA